Publications by authors named "Gary Stump"

Claim this Profile
D
Data on the design and operation of drones by both individuals and teams.
Guanglu Zhang, Nicolas F Soria Zurita, Gary Stump, Binyang Song, Jonathan Cagan

Data Brief· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of an investigative safety pharmacology model to assess comprehensive cardiac function and structure in chronically instrumented conscious beagle dogs.
Christopher P Regan, Gary L Stump, Theodore J Detwiler, Li Chen, Hillary K Regan

J Pharmacol Toxicol Methods· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of MK-1832, a Kv1.5 inhibitor with improved selectivity and pharmacokinetics.
Scott E Wolkenberg, M Brad Nolt, Mark T Bilodeau, B Wesley Trotter, Peter J Manley, Gary L Stump

Bioorg Med Chem Lett· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MK-0448, a specific Kv1.5 inhibitor: safety, pharmacokinetics, and pharmacodynamic electrophysiology in experimental animal models and humans.
Behzad B Pavri, Howard E Greenberg, Walter K Kraft, Nicole Lazarus, Joseph J Lynch, Gary Stump

Circ Arrhythm Electrophysiol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prototype serotonin 5-HT 1B/1D agonist sumatriptan increases the severity of myocardial ischemia during atrial pacing in dogs with coronary artery stenosis.
Joseph J Lynch, Gary L Stump, Stefanie A Kane, Christopher P Regan

J Cardiovasc Pharmacol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Calcitonin gene-related peptide receptor antagonism does not affect the severity of myocardial ischemia during atrial pacing in dogs with coronary artery stenosis.
Christopher P Regan, Gary L Stump, Stefanie A Kane, Joseph J Lynch

J Pharmacol Exp Ther· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemodynamic and cardiac neurotransmitter-releasing effects in conscious dogs of attention- and wake-promoting agents: a comparison of d-amphetamine, atomoxetine, modafinil, and a novel quinazolinone H3 inverse agonist.
Joseph Lynch, Christopher Regan, Gary Stump, Pamela Tannenbaum, Joanne Stevens

J Cardiovasc Pharmacol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atrial antifibrillatory effects of structurally distinct IKur blockers 3-[(dimethylamino)methyl]-6-methoxy-2-methyl-4-phenylisoquinolin-1(2H)-one and 2-phenyl-1,1-dipyridin-3-yl-2-pyrrolidin-1-yl-ethanol in dogs with underlying heart failure.
Christopher P Regan, Laszlo Kiss, Gary L Stump, Charles J McIntyre, Douglas C Beshore

J Pharmacol Exp Ther· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclic benzamidines as orally efficacious NR2B-selective NMDA receptor antagonists.
Kevin T Nguyen, Christopher F Claiborne, John A McCauley, Brian E Libby, David A Claremon, Gary L Stump

Bioorg Med Chem Lett· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo cardiac electrophysiologic and antiarrhythmic effects of an isoquinoline IKur blocker, ISQ-1, in rat, dog, and nonhuman primate.
Christopher P Regan, Gary L Stump, Audrey A Wallace, Kenneth D Anderson, Charles J McIntyre

J Cardiovasc Pharmacol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterization of 4-methylbenzyl 4-[(pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate, an orally bioavailable, brain penetrant NR2B selective N-methyl-D-aspartate receptor antagonist.
Nigel J Liverton, Rodney A Bednar, Bohumil Bednar, John W Butcher, Christopher F Claiborne, Gary L Stump

J Med Chem· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent antagonists of the Kv1.5 potassium channel: synthesis and evaluation of analogous N,N-diisopropyl-2-(pyridine-3-yl)acetamides.
Kausik K Nanda, M Brad Nolt, Matthew J Cato, Stefanie A Kane, Laszlo Kiss, Gary L Stump

Bioorg Med Chem Lett· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of novel isoquinoline-3-nitriles as orally bioavailable Kv1.5 antagonists for the treatment of atrial fibrillation.
B Wesley Trotter, Kausik K Nanda, Nathan R Kett, Christopher P Regan, Joseph J Lynch, Gary L Stump

J Med Chem· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Block of peripheral nerve sodium channels selectively inhibits features of neuropathic pain in rats.
Richard M Brochu, Ivy E Dick, Jason W Tarpley, Erin McGowan, David Gunner, Gary L Stump

Mol Pharmacol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo antiarrhythmic and cardiac electrophysiologic effects of a novel diphenylphosphine oxide IKur blocker (2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide.
Gary L Stump, Audrey A Wallace, Christopher P Regan, Joseph J Lynch

J Pharmacol Exp Ther· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NR2B-selective N-methyl-D-aspartate antagonists: synthesis and evaluation of 5-substituted benzimidazoles.
John A McCauley, Cory R Theberge, Joseph J Romano, Susan B Billings, Kenneth D Anderson, Gary L Stump

J Med Chem· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo canine cardiac electrophysiologic profile of 1,4-benzodiazepine IKs blockers.
Gary L Stump, Garry R Smith, Andrew J Tebben, Hossain Jahansouz, Joseph J Salata

J Cardiovasc Pharmacol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzodiazepines as potent and selective bradykinin B1 antagonists.
Michael R Wood, June J Kim, Wei Han, Bruce D Dorsey, Carl F Homnick, Gary L Stump

J Med Chem· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-peptide alphavbeta3 antagonists. Part 6: design and synthesis of alphavbeta3 antagonists containing a pyridone or pyrazinone central scaffold.
Michael J Breslin, Mark E Duggan, Wasyl Halczenko, Carmen Fernandez-Metzler, Cecilia A Hunt, Gary Stump

Bioorg Med Chem Lett· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orally efficacious NR2B-selective NMDA receptor antagonists.
Christopher F Claiborne, John A McCauley, Brian E Libby, Neil R Curtis, Helen J Diggle, Gary L Stump

Bioorg Med Chem Lett· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiarrhythmic efficacy of combined I(Ks) and beta-adrenergic receptor blockade.
Joseph J Lynch, Joseph J Salata, Audrey A Wallace, Gary L Stump, David B Gilberto

J Pharmacol Exp Ther· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-peptide alpha(v)beta(3) antagonists. Part 3: identification of potent RGD mimetics incorporating novel beta-amino acids as aspartic acid replacements.
Paul J Coleman, Karen M Brashear, Cecilia A Hunt, William F Hoffman, John H Hutchinson, Gary L Stump

Bioorg Med Chem Lett· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis